🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

SWEEP: Shuttle Walking Test for Exercise Evaluation in Pulmonary Resection

Recruitingn/aAges 40 Years - anyAllSeoul National University Bundang Hospital
NCT07102589 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a prospective observational study that evaluates whether the Shuttle Walking Test (SWT) can predict postoperative symptoms, particularly dyspnea, in patients with chronic respiratory diseases undergoing lung resection. Currently, tools such as DLCO or cardiopulmonary exercise testing (CPET) are used to assess surgical risk and exercise capacity before lung surgery. However, these tests are not always accessible due to equipment limitations or long waiting times. The SWT is a simpler, safer, and more cost-effective alternative that has been recently recognized as a new medical technology in Korea for evaluating exercise capacity. In this study, patients with chronic lung diseases (such as COPD, ILD, or bronchiectasis) who are scheduled to undergo lung resection will perform the SWT before surgery. Their symptoms and quality of life will be assessed through questionnaires before

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * \- Age ≥ 40 years * Scheduled for surgical lung resection (e.g., for lung cancer or benign tumor) * Diagnosis of chronic respiratory disease (COPD, ILD, or bronchiectasis) * Able to perform Shuttle Walking Test (ISWT + ESWT) before surgery * Able to complete pre- and postoperative symptom questionnaires (dyspnea, EQ-5D) Exclusion Criteria: * \- Illiteracy or inability to read study materials * Inability to communicate in Korean * Decline or withdraw consent * Severe lower limb disability interfering with walking (e.g., fracture, paralysis)
💊

What it tests

  • Not listed
📍

Where

1 site
Seoul National University Bundang Hospital
Seongnam-si, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy